Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 704678, 8 pages
http://dx.doi.org/10.1155/2014/704678
Research Article

Increased DJ-1 in Urine Exosome of Korean Males with Parkinson’s Disease

1InAm Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University, Sanbon-dong, Gunpo-si, Gyeonggi-do, Republic of Korea
2Department of Molecular and Life Sciences, Hanyang University, Ansan-si, Gyeonggi-do, Republic of Korea
3Department of Neurology, Sanbon Medical Center, College of Medicine, Wonkwang University, Sanbon-dong, Gunpo-si, Gyeonggi-do, Republic of Korea

Received 13 June 2014; Revised 12 August 2014; Accepted 27 August 2014; Published 13 November 2014

Academic Editor: Alessandro Stefani

Copyright © 2014 Dong Hwan Ho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. A. Zesiewicz, M. J. Baker, M. Wahba, and R. A. Hauser, “Autonomic nervous system dysfunction in Parkinson's disease,” Current Treatment Options in Neurology, vol. 5, no. 2, pp. 149–160, 2003. View at Publisher · View at Google Scholar
  2. R. F. Pfeiffer, “Gastrointestinal dysfunction in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 17, no. 1, pp. 10–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. J. Garcia-Ruiz, K. R. Chaudhuri, and P. Martinez-Martin, “Non-motor symptoms of Parkinson's disease A review.from the past,” Journal of the Neurological Sciences, vol. 338, no. 1-2, pp. 30–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Russo, L. Bubacco, and E. Greggio, “Exosomes-associated neurodegeneration and progression of Parkinson's disease,” American Journal of Neurodegenerative Disease, vol. 1, no. 3, pp. 217–225, 2012. View at Google Scholar
  5. E. J. Hoorn, T. Pisitkun, R. Zietse et al., “Prospects for urinary proteomics: exosomes as a source of urinary biomarkers,” Nephrology, vol. 10, no. 3, pp. 283–290, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Zhou, P. S. T. Yuen, T. Pisitkun et al., “Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery,” Kidney International, vol. 69, no. 8, pp. 1471–1476, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Knepper and T. Pisitkun, “Exosomes in urine: who would have thought...?” Kidney International, vol. 72, no. 9, pp. 1043–1045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Martin, V. L. Dawson, and T. M. Dawson, “Recent advances in the genetics of parkinson's disease,” Annual Review of Genomics and Human Genetics, vol. 12, pp. 301–325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Seol, “Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease,” BMB Reports, vol. 43, no. 4, pp. 233–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. K. B. Fraser, M. S. Moehle, J. P. L. Daher et al., “LRRK2 secretion in exosomes is regulated by 14-3-3,” Human Molecular Genetics, vol. 22, no. 24, Article ID ddt346, pp. 4988–5000, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Pisitkun, R.-F. Shen, and M. A. Knepper, “Identification and proteomic profiling of exosomes in human urine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 36, pp. 13368–13373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Kasuga, M. Nishizawa, and T. Ikeuchi, “α-synuclein as CSF and blood biomarker of dementia with lewy bodies,” International Journal of Alzheimer's Disease, vol. 2012, Article ID 437025, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Tokuda, M. M. Qureshi, M. T. Ardah et al., “Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease,” Neurology, vol. 75, no. 20, pp. 1766–1772, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M.-C. Chartier-Harlin, J. Kachergus, C. Roumier et al., “α-synuclein locus duplication as a cause of familial Parkinson's disease,” The Lancet, vol. 364, no. 9440, pp. 1167–1169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. B. Singleton, M. Farrer, J. Johnson et al., “α-synuclein locus triplication causes parkinson's disease,” Science, vol. 302, no. 5646, p. 841, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Fuchs, C. Nilsson, J. Kachergus et al., “Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication,” Neurology, vol. 68, no. 12, pp. 916–922, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. E. Daniel and A. J. Lees, “Parkinson's Disease Society Brain Bank, London: overview and research,” Journal of Neural Transmission: Supplementum, vol. 39, pp. 165–172, 1993. View at Google Scholar · View at Scopus
  18. Z. Wang, S. Hill, J. M. Luther, D. L. Hachey, and K. L. Schey, “Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT),” Proteomics, vol. 12, no. 2, pp. 329–338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Cheruvanky, H. Zhou, T. Pisitkun et al., “Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator,” The American Journal of Physiology—Renal Physiology, vol. 292, no. 5, pp. F1657–F1661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Y. Chen, M. C. Hogan, and C. J. Ward, “Purification of exosome-like vesicles from urine,” Methods in Enzymology, vol. 524, pp. 225–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. L. Merchant, D. W. Powell, D. W. Wilkey et al., “Microfiltration isolation of human urinary exosomes for characterization by MS,” Proteomics: Clinical Applications, vol. 4, no. 1, pp. 84–96, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Santucci, G. Candiano, M. Bruschi et al., “Urinary proteome in a snapshot: normal urine and glomerulonephritis,” Journal of Nephrology, vol. 26, no. 4, pp. 610–616, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. B. A. Julian, H. Suzuki, Y. Suzuki, Y. Tomino, G. Spasovski, and J. Novak, “Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease,” Proteomics—Clinical Applications, vol. 3, no. 9, pp. 1029–1043, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Caranci, P. Piscopo, R. Rivabene et al., “Gender differences in Parkinson's disease: focus on plasma alpha-synuclein,” Journal of Neural Transmission, vol. 120, no. 8, pp. 1209–1215, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Su, M. J. Bell, S. R. Wisniewski et al., “α-synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia,” Developmental Neuroscience, vol. 32, no. 5-6, pp. 385–395, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Simunovic, M. Yi, Y. Wang, R. Stephens, and K. C. Sonntag, “Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease,” PLoS ONE, vol. 5, no. 1, Article ID e8856, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Tokuda, S. A. Salem, D. Allsop et al., “Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease,” Biochemical and Biophysical Research Communications, vol. 349, no. 1, pp. 162–166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J. H. Kordower, C. W. Olanow, H. B. Dodiya et al., “Disease duration and the integrity of the nigrostriatal system in Parkinson's disease,” Brain, vol. 136, no. 8, pp. 2419–2431, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Properzi, M. Logozzi, and S. Fais, “Exosomes: the future of biomarkers in medicine,” Biomarkers in Medicine, vol. 7, no. 5, pp. 769–778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Cuevas, Y. Zhang, Y. Yang et al., “Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production,” Hypertension, vol. 59, no. 2, pp. 446–452, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Paisán-Ruíz, S. Jain, E. W. Evans et al., “Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease,” Neuron, vol. 44, no. 4, pp. 595–600, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Zimprich, S. Biskup, P. Leitner et al., “Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology,” Neuron, vol. 44, no. 4, pp. 601–607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. J. Park, S.-M. Cheon, H.-R. Bae, S.-H. Kim, and J. W. Kim, “Elevated levels of α-synuclein oligomer in the cerebrospinal fluid of drug-naïve patients with Parkinson's disease,” Journal of Clinical Neurology, vol. 7, no. 4, pp. 215–222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. C. M. Clements, R. S. McNally, B. J. Conti, T. W. Mak, and J. P.-Y. Ting, “DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 41, pp. 15091–15096, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Saito, “Oxidized DJ-1 as a possible biomarker of Parkinson's disease,” Journal of Clinical Biochemistry and Nutrition, vol. 54, no. 3, pp. 138–144, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Y. Kang, Q. Yang, X. F. Jiang et al., “Salivary DJ-1 could be an indicator of Parkinson's disease progression,” Frontiers in Aging Neuroscience, vol. 6, p. 102, 2014. View at Google Scholar
  37. X. Lin, T. J. Cook, C. P. Zabetian et al., “DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease,” Scientific Reports, vol. 2, article 954, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Cantuti-Castelvetri, C. Keller-McGandy, B. Bouzou et al., “Effects of gender on nigral gene expression and parkinson disease,” Neurobiology of Disease, vol. 26, no. 3, pp. 606–614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Baldereschi, A. Di Carlo, W. A. Rocca et al., “Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men,” Neurology, vol. 55, no. 9, pp. 1358–1363, 2000. View at Publisher · View at Google Scholar · View at Scopus